Cytokine production in the brain following closed head injury: Dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant

Journal of Neuroimmunology

Volumn 72, Issue 2, 1997, Pages 169-177

  Shohami, E ^a   Gallily, R ^b   Mechoulam, R ^a   Bass, R ^a   Ben Hur, T ^c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

blood brain barrier; closed head injury; dexanabinol (HU 211); edema; tumor necrosis factor (TNF )

Indexed keywords

DEXANABINOL; MESSENGER RNA; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURY; CONFERENCE PAPER; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; BRAIN INJURIES; CYTOKINES; EXCITATORY AMINO ACID ANTAGONISTS; HEAD INJURIES, CLOSED; NEUROPROTECTIVE AGENTS; TETRAHYDROCANNABINOL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031047431     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00181-6     Document Type: Conference Paper

References (60)

1. Bar-Joseph, A., Berkovitch, Y., Adamchik, J. and Biegon, A. (1994) Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils. Mol. Chem. Neuropathol. 23, 125-135.
2. Bass, R., Engelhard, D., Trembovler, V. and Shohami, E. (1996) A novel nonpsychotropic cannabinoid, HU-211, in the treatment of experimental pneumococcal meningitis. J. Infect. Dis. 173, 745-738.
3. Bazan, N.G. (1989) Arachidonic acid (AA) in the modulation of excitable membrane function and at the onset of brain damage. Ann. NY Acad. Sci. 559, 1-16.
4. Belayev, L., Busto, R., Zhao, W. and Ginsberg, M.D. (1995a) HU-211, a novel noncompetitive N-methyl-D-aspartate antagonist improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. Stroke 26, 2313-2320.
5. Belayev, L., Busto, R., Watson, B.D. and Ginsberg, M.D. (1995b) Post-ischemic administration of HU-211, a novel non-competitive NMDA antagonist, protects against blood brain barrier disruption inphotochemocal cortical infarction in rats: A quantitative study. Brain Res. 702, 266-270.
6. Benveniste, H., Drejer, J., Schousboe, A. and Diemer, N.H. (1984) Elevation of extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374.
7. Beutler, B., Korchin, N., Milsark, J.W., Luedke, C. and Cerami, A. (1986) Control of cachectin (Tumor Necrosis Factor) synthesis: Mechanism of endotoxin resistance. Science 232, 977-980.
8. Brenner, T., Yamin, A., Abramsky, O. and Gallily, R. (1993) Stimulation of tumor necrosis factor-production by mycoplasmas and inhibition by dexamethasone in cultured astrocytes. Brain Res. 608, 273-279.
9. Chao, C.C., Hu, S., Ehrlich, L. and Peterson, P.K. (1995) Interleukin-1 and Tumor Necrosis Factor-α synergistically mediate neurotoxicity: Involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav. Immunol. 9, 355-365.
10. Chirgwin J.M., Pryzbla, A.E., MacDonald, R.S., et al. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochem. 18, 5294-5299.
11. Choi, D.W. (1993) NMDA receptors and AMPA/kainate receptors mediate parallel injury in cerebral cortical cultures subjected to oxygen-glucose deprivation. In: K. Kogure, K.A. Hossmann and B.K. Siesjo (Eds.), Progress in Brain Research, Vol. 96. Elsevier, Amsterdam, pp 137-143.
12. Cohen, P.S., Nakshatri, H., Dennis, J., Caragine, T., Bianchi, M., Cerami, A. and Tracey, K.J., (1996) CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc. Natl. Acad. Sci. USA 93, 3967-3971.
13. Diemer, N.H., Valente, E., Bruhn, T., Berg, M., Jorgensen, M.B. and Johansen, F.F. (1993) Glutamate receptor transmission and ischemic nerve cell damage: Evidence for involvement of excitotoxic mechanisms. In: K. Kogure, K.A. Hossmann and B.K. Siesjo (Eds.), Progress in Brain Research, Vol. 96. Elsevier Science Publishers B.V., Amsterdam, pp. 105-123.
14. Dinarello, C.A. (1988) Cytokines: Interleukin-1 and tumor necrosis factor (cachectin). In: J.I. Gallin, M.L. Goldstein and R. Snyderman (Eds.), Inflammation: Basic Principles and Clinical Correlates. Raven Press, New York, pp. 195-208.
15. Eshhar, N., Striem, S. and Biegon, A. (1993) HU-211, a non-psychotropic cannabinoid, rescues cortical neurons from excitatory amino acid toxicity in culture, NeuroReport 5, 237-240.
16. Faden, A.I., (1993) Experimental neurobiology of central nervous system injury. In: C.B. Nemeroff (Ed.), Critical Reviews in Neurobiology. CRC, Boca Raton, FL, pp. 175-186.
17. Fan, L., Young, P.R., Barone, F.C., Feuerstein, G., Smith. D.H. and McIntosh, T.K. (1996) Experimental brain injury induces differential expression of tumor necrosis factor-α mRNA in the CNS. Mol. Brain Res. 36, 287-291.
18. Feigenbaum, J.J., Bergmann, F., Richmond, S.A., Mechoulam, R., Nadler, V., Kloog, Y. and Sokolovsky, M. (1989) Non-psychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. Proc. Natl. Acad. Sci. USA 86, 9584-9587.
19. Feuerstein, G.Z., Liu, T. and Barone, F.C. (1994) Cytokines, inflammation and brain injury-role for tumor necrosis factor-alpha. Cereb. Brain 6, 341-367.
20. Goodman, J.C., Robertson, C.S., Grossman, R.G. and Narayan, R.K. (1990) Elevation of tumor necrosis factor in head injury. J. Neuroimmunol. 30, 213-217.
21. Klatzo, I. (1967). Neuropathological aspects of brain oedema. J. Neuropath. Exp. Neurol. 26, 1-14.
22. Kontos, H.A. (1989) Oxygen radicals in central nervous system damage. Chem. Biol. Interact. 72, 229-255.
23. Levin, H.S. (1985). Outcome after head injury: General considerations and neurobehavioral recovery, Part II. Neurobehavioral Recovery. In: D.P. Becker and J.T. Povlishock (Eds.), Central Nervous System Status Report. NINCDS and NIH, Washington, DC, pp. 281-299.
24. Little, P.J., Compton, D.R., Mechoulam, R. and Martin, B. (1989) Stereochemical effects of 11-OH-delta-8-THC-dimethylheptyl in mice and dogs. Pharmacol. Biochem. Behav. 32, 661-666.
25. Liu, T., Clark, R.K., McDonnel, P.C., Toung, P.R., White, R.F., Barone, F.C. and Feuerstein, F.Z. (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25, 1481-1488.
26. McIntosh, T.K. (1993) Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: A review. J. Neurotrauma 10, 215-262.
27. Mechoulam, R., Feigenbaum, J.J., Lander, N., Segal, M., Jarbe, T.U.C., Hiltunen, A.J. and Consore, P. (1988). Enantiomeric cannabinoids: Stereospecificity of psycotropic activity. Experientia 44, 762-764.
28. Mechoulam, R., Lander, N., Breuer, A. and Zahalka, J. (1990) Synthesis of the individual, pharmacologically distinct, enantiomers of a tetrahydrocannabinol derivative. Tetrahedron Asym. 1, 315-319.
29. Mechoulam, R., Devane, W.A. and Glaser, R. (1992) Cannabinoid geometry and biological activity. In: L. Murphy and A. Bartke (Ed.), Marijuana/cannabinoids: Neurobiology and neurophysiology. CRC Press, Boca Raton, FL, pp. 1-33.
30. Mier, J.W., Vechino G., Numeruf, R.P., Kotik, A.N and Atkins, M.B. (1992) Effects of IL-2 and IL-4 on synthesis of TNF. In: B. Beutler, (Ed.), Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. Raven Press, NY, pp. 221-236.
31. Morganti-Kossmann, M.C. and Kossmann, T. (1995) The immunology of brain injury: In: Immune responses in the central nervous system. Bios Scientific Publishers, Oxford, UK, pp. 159-187.
32. Morganti-Kossmann, M.C., Kossmann, T. and Wahl, S.M. (1992) Cytokines and neurophathology. Trends Pharmacol. Sci. 13, 286-291.
33. Morris, R.G.M., Garrud, P., Rawlins, J.N.P. and O'Keefe, J. (1982). Place navigation impaired in rats with hippocampal lesions. Nature 297, 681-683.
34. Nadler, V., Biegon, A., Beit-Yannai, E., Adamchik, J. and Shohami, E. (1995) Ca accumulation in rat brain after closed head injury: Attenuation by the novel neuroprotective agent HU-211. Brain Res. 685, 1-11.
35. 6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates NMDA receptor-mediated neurotoxicity in primary cultures of rat forebrain. Neurosci. Lett. 162, 43-45.
36. 2+ influx through the N-methyl-D-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211. Brain Res. 622, 79-85.
37. Nophar, Y., Kemper, O., Brakebusch, C., Engelmann, H., Zwang, R., Aderka, D., Holtmann, H. and Wallach, D. (1990) Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J. 9, 3269-3278.
38. Olney, J.W., (1978) Neurotoxicity of excitatory amino acids. In: E.G. McGeer, J.W. Olney and P.L. McGeer (Eds.), Kainic Acid as a Tool in Neurobioloy. Raven Press, New York, pp. 37-70.
39. Remick, D.G., Nguyen, D.T., Eskandari, M., Strieer, R.M. and Kunkel, S.L. (1989) Cyclosporine A inhibits TNF production without decreasing TNF mRNA levels. Biochem. Biophys. Res. Comm. 161, 551-555.
40. Ross, S.A., Halliday, M.I., Campbell, G.C, Byrnes, D.P. and Rowlands, B.J. (1994) The presence of tumor necrosis factor in CSF and plasma after severe head injury. Br. J. Neurosurg. 8, 419-425.
41. Rothwell, N.J. and Hopkins, S.J. (1995) Cytokines and the nervous system II: Action and mechanisms of action. Trends Neurosci. 18, 130-136.
42. Sawada, M., Knodo, N., Suzumura, A. and Marunouchi, T. (1989) Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491, 394-397.
43. Shapira, Y., Setton, D., Artru, A. and Shohami, E. (1993) Blood brain barrier, cerebral edema and neurological function following closed head injury in the rats. Anesth. Analg. 77, 141-148.
44. Shapira, Y., Shohami, E., Sidi, A., Soffer, D., Freeman, S. and Cotev, S. (1988) Experimental closed head injury in rats: Mechanical, pathophysiologic and neurologic properties. Crit. Care Med. 16, 258-265.
45. Shohami, E., Bass, R., Wallach, D., Yamin, A. and Gallily, R. (1996) Inhibition of tumor necrosis factor (TNF) activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 16, 378-384.
46. Shohami, E., Novikov, M. and Bass, R., (1995) Long term effect of HU-211, a novel noncompetitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res. 674, 55-62.
47. Shohami, E., Novikov, M., Bass, R., Yamin, A. and Gallily, R. (1994) Closed head injury triggers early production of TNF and IL-6 by brain tissue. J. Cereb. Blood Flow Metab. 14, 615-619.
48. Shohami, E., Novikov, M. and Mechoulam, R. (1993) A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat. J. Neurotrauma, 10, 109-119.
49. 2 is activated after experimental closed head injury in rats. J. Neurochem. 53, 1541-1546.
50. Siesjo, B.K. (1988) Historical review: Calcium, ischemia and death of brain cells. Ann. NY Acad. Sci. 522, 638-661.
51. Spangelo, B.L., Judd, A.M., MacLeod, R.M., Goodman, D.W. and Isakson, P.C. (1990) Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami. Endocrinology 127, 1779-1785.
52. Taupin, V., Toulmond, S., Serrano, A., Benavides, J. and Zavala, F. (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with RO5 4874, a peripheral-type (p-site) benzodiazepine ligand. J. Neu-roimmunol. 42, 177-185.
53. Tracey, K.J. (1991) Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ. Shock 35, 123-128.
54. Tracey, K.J. and Lowry, S.F. (1990) The role of cytokine mediators in septic shock. Adv. Surg. 23, 21-56.
55. Waage, A. (1992) Presence and involvement of TNF in septic shock. In: B. Beutler (Ed.), Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine. Raven Press, NY, pp. 275-283.
56. Watkins, L.R., Maier, S.F. and Goehler, L.E. (1995) Minireview: Cytokine-to-brain communication: A review and analysis of alternative mechanisms. Life Sci. 57, 1011-1026.
57. Waxweiler, R.J., Thutman, D., Sniezek, J., Sosin D. and O'Neil, J. (1995) Monitoring the impact of traumatic brain injury: A review and update. J. Neurotrauma 12, 509-516.
58. Westmoreland, S.V., Kolson, D. and Gonzalez-Scarano, F. (1996) Toxic -ity of TNFα and platelet activating factor for human NT2N neurons: A tissue culture model for human immunodeficiency virus dementia. J Neurovirol. 2, 118-126.
59. Woodroofe, M.N., Sarna, G.S., Wadhwa, M., Hayes, G.M., Loughlin, A.J., Tinker, A. and Cuzner, M.L. (1991) Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: Evidence of a role for microglia in cytokine production. J. Immunol. 33, 227-236.
60. Zabel, P., Schonharting, M.M., Wolter, D.T. and Schade, U.F. (1989) Oxpentifylline in endotoxemia. Lancet 2, 1474-1477.